Symbicort is an asthma treatment from AstraZeneca International consisting of the inhaled corticosteroid budesonide that prevents the release of substances in the body that cause inflammation and Formoterol, a bronchodilator, that dilates the respiratory tract to improve breathing. Symbicort is used to prevent bronchospasm in people with asthma or chronic obstructive pulmonary disease (COPD). Money-saving deals such as coupons, patient assistance programs and free month’s supply of medicine are available to eligible patients. In addition, Aster Zeneca, maker of Symbicort, has more than one patient assistance program for asthma and COPD patients who cannot afford medication. See here for more details.